Cargando…
Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report
BACKGROUND: We describe a case of pemetrexed toxicities related to reabsorption by an ileal neobladder, which caused prolonged hematotoxicity and nephrotoxicity. CASE PRESENTATION: A 59-year-old white man was diagnosed with metastatic wild-type adenocarcinoma of the upper lobe of his right lung. Aft...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603063/ https://www.ncbi.nlm.nih.gov/pubmed/28915906 http://dx.doi.org/10.1186/s13256-017-1436-7 |
_version_ | 1783264668572188672 |
---|---|
author | Sakhri, Linda Pinsolle, Julian Moro-Sibilot, Denis Pluchart, Hélène |
author_facet | Sakhri, Linda Pinsolle, Julian Moro-Sibilot, Denis Pluchart, Hélène |
author_sort | Sakhri, Linda |
collection | PubMed |
description | BACKGROUND: We describe a case of pemetrexed toxicities related to reabsorption by an ileal neobladder, which caused prolonged hematotoxicity and nephrotoxicity. CASE PRESENTATION: A 59-year-old white man was diagnosed with metastatic wild-type adenocarcinoma of the upper lobe of his right lung. After a first cycle of cisplatin and pemetrexed, he had unusually prolonged aplasia and acute kidney injury. The prolonged aplasia was caused by pemetrexed reabsorption by the ileal mucosa of the neobladder as pemetrexed was eliminated renally in an active form and is partly lipophilic. CONCLUSIONS: Pemetrexed may be reabsorbed by the ileal mucosa of the neobladder because of its hydrophobic structure and renal excretion in its active form. Acute urinary retention may maintain this phenomenon. Published data excluded a potential role for cisplatin in this toxicity; furthermore, we could not assess pemetrexed concentrations in the blood or urine as these assay techniques are not validated. Thus, care is needed when giving chemotherapy to patients with a neobladder. |
format | Online Article Text |
id | pubmed-5603063 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56030632017-09-20 Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report Sakhri, Linda Pinsolle, Julian Moro-Sibilot, Denis Pluchart, Hélène J Med Case Rep Case Report BACKGROUND: We describe a case of pemetrexed toxicities related to reabsorption by an ileal neobladder, which caused prolonged hematotoxicity and nephrotoxicity. CASE PRESENTATION: A 59-year-old white man was diagnosed with metastatic wild-type adenocarcinoma of the upper lobe of his right lung. After a first cycle of cisplatin and pemetrexed, he had unusually prolonged aplasia and acute kidney injury. The prolonged aplasia was caused by pemetrexed reabsorption by the ileal mucosa of the neobladder as pemetrexed was eliminated renally in an active form and is partly lipophilic. CONCLUSIONS: Pemetrexed may be reabsorbed by the ileal mucosa of the neobladder because of its hydrophobic structure and renal excretion in its active form. Acute urinary retention may maintain this phenomenon. Published data excluded a potential role for cisplatin in this toxicity; furthermore, we could not assess pemetrexed concentrations in the blood or urine as these assay techniques are not validated. Thus, care is needed when giving chemotherapy to patients with a neobladder. BioMed Central 2017-09-16 /pmc/articles/PMC5603063/ /pubmed/28915906 http://dx.doi.org/10.1186/s13256-017-1436-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Sakhri, Linda Pinsolle, Julian Moro-Sibilot, Denis Pluchart, Hélène Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report |
title | Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report |
title_full | Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report |
title_fullStr | Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report |
title_full_unstemmed | Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report |
title_short | Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report |
title_sort | unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603063/ https://www.ncbi.nlm.nih.gov/pubmed/28915906 http://dx.doi.org/10.1186/s13256-017-1436-7 |
work_keys_str_mv | AT sakhrilinda unusuallyprolongedpemetrexedcytotoxicityinapatientwithalungadenocarcinomaacasereport AT pinsollejulian unusuallyprolongedpemetrexedcytotoxicityinapatientwithalungadenocarcinomaacasereport AT morosibilotdenis unusuallyprolongedpemetrexedcytotoxicityinapatientwithalungadenocarcinomaacasereport AT plucharthelene unusuallyprolongedpemetrexedcytotoxicityinapatientwithalungadenocarcinomaacasereport |